Ernest Mario School of Pharmacy, Pharmacy Practice and Administration – Health Outcomes, Policy & Economics, Rutgers University is part of Rutgers Biomedical Health Sciences (RBHS) and participates in interdisciplinary professional education and training partnership with Rutgers School of Public Health and the Robert Wood Johnson Medical School.
The Ernest Mario School of Pharmacy, Pharmacy Practice and Administration – Health Outcomes, Policy & Economics, Rutgers University Fellowship Program offers a significant opportunity to individuals interested in real world evidence data analytics and the broader field of health economics & outcomes research (HE&OR).
Fellowship program provides robust learning experiences related to the science and application of health economics and outcomes research:
This program, in partnership with Janssen Scientific Affairs, LLC, part of Janssen Pharmaceutical Companies of Johnson & Johnson, Real World Value & Evidence (RWV&E) group, offers a significant opportunity to individuals interested in health economics, cost and services utilization analysis, and patient-reported outcomes research.
The Fellow will be employed for up to two years by Rutgers University and will work onsite with researchers at Janssen Scientific Affairs, LLC RWV&E offices located in Titusville, NJ. Examples of the postdoctoral associate’s activities include:
Contributing to trial design planning to incorporate patient-reported outcomes (PROs) and health economic measures through conducting evidence-based literature reviews and PRO questionnaire evaluation.
Conducting burden of illness evaluations to better characterize patient and population unmet needs through database analysis and literature reviews. Developing health economic models to characterize and communicate the budget impact and cost-effectiveness of new or existing therapeutics.
Conducting comparative effectiveness research using Real World Data.
Participating in cross-functional teams in an effort to gain a better understanding of how real world evidence can be used in the decision-making process associated with the development and commercialization of new pharmaceutical products.